Ildiko Antal‐Zimanyi

Eleven Amino Acid Glucagon-like Peptide-1 Receptor Agonists with Antidiabetic Activity

Claudio Mapelli, Sesha Natarajan, Jean‐Philippe Meyer et al. · Journal of Medicinal Chemistry · 2009 · 70 citations · Full text

Metabolic Syndrome, Diabetes Management, Peptides 21 +15

Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y1 receptor antagonist

Ildiko Antal‐Zimanyi, Marc A. Bruce, Karen L. LeBoulluec et al. · European Journal of Pharmacology · 2008 · 34 citations

Molecular Pharmacology, Neuropeptides, Pharmacological Characterization +10

Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists

Kevin W. Gillman, Mendi A. Higgins, Graham S. Poindexter et al. · Bioorganic & Medicinal Chemistry · 2006 · 23 citations

Molecular Pharmacology, Medicine, Neuropeptide Receptor +5

Isosteric N-arylpiperazine replacements in a series of dihydropyridine NPY1 receptor antagonists

Guanglin Luo, Gail K. Mattson, Marc A. Bruce et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 21 citations · Full text

Isosteric N-arylpiperazine Replacements, Functional Selectivity, Medicine +4

Novel Dihydropyrazine Analogues as NPY Antagonists

Sing‐Yuen Sit, Yazhong Huang, Ildiko Antal‐Zimanyi et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 20 citations · Full text

Novel Dihydropyrazine Analogues, Medicine, Pharmacological Agent +5